Breaking News Instant updates and real-time market news.

SRPT

Sarepta

$143.85

38.37 (36.38%)

13:35
06/19/18
06/19
13:35
06/19/18
13:35

Sarepta price target raised to $205 from $87 at JPMorgan

JPMorgan analyst Anupam Rama said he is adding Sarepta's micro-dystrophin program to his model following the company's R&D day, reiterating his earlier call that the update "vastly exceeded" expectations. He estimates peak sales of $4B-$5B for the micro-dystrophin program, adding that the breadth of the pipeline highlighted at the R&D day leads him to believe Sarepta has the potential to enter the ranks of the "emerging large-caps" in the next 12-24 months. Rama raised his price target on Sarepta to $205 from $87 and keeps an Overweight rating on the shares.

  • 20

    Jun

SRPT Sarepta
$143.85

38.37 (36.38%)

06/15/18
BTIG
06/15/18
INITIATION
Target $120
BTIG
Buy
Sarepta initiated with a Buy at BTIG
BTIG analyst Timothy Chiang started Sarepta Therapeutics with a Buy rating and $120 price target. The company is the leader in the Duchenne muscular dystrophy space with its Exondys 51 estimated to generate sales of $300M in 2018, and its "extensive pipeline" of RNA-splicing product candidates, Chiang tells investors in a research note. While the stock is up 78% year-to-date, there is the potential for further upside as investors get additional visibility on Sarepta's gene therapy and phosphorodiamidate morpholino oligomer programs, the analyst contends.
06/15/18
JPMS
06/15/18
NO CHANGE
JPMS
Overweight
JPMorgan sees favorable setup for Sarepta into Tuesday's event
JPMorgan analyst Anupam Rama sees a favorable setup for shares of Sarepta Therapeutics(SRPT) into the company's R&D day on Tuesday, June 19. His scenario analysis points to a "very favorable" reward/risk profile of 20%-50% upside versus 10%-25% downside. If the gene therapy data meets or beats expectations, Sarepta will clearly be in the pole position in the micro-dystrophin space, Rama tells investors in a research note. The analyst adds that if the Sarepta micro-dystrophin data are viewed positively next week, a clear bar will have been set that Solid Biosciences (SLDB) will need to meet or beat. Rama continues to see risk to Solid shares ahead of next week's readout from Sarepta. He has an Overweight rating on Sarepta with an $87 price target and Underweight rating on Solid Biosciences with a $10 price target.
06/15/18
06/15/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. PetMed Express (PETS) initiated with a Neutral at CL King. 2. Cloudera (CLDR) initiated with a Reduce at Nomura Instinet. 3. Sarepta (SRPT) initiated with a Buy at BTIG. 4. Delphi Technologies (DLPH) initiated with a Perform at Oppenheimer. 5. Enerplus (ERF) initiated with a Buy at SunTrust. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/19/18
JPMS
06/19/18
NO CHANGE
JPMS
Sarepta data beat 'grand slam scenario,' says JPMorgan
JPMorgan analyst Anupam Rama says the micro-dystrophin data reported this morning by Sarepta Therapeutics beat his "grand slam scenario." The stock in morning trading is up 59% to $166.99.

TODAY'S FREE FLY STORIES

RLGY

Realogy

$11.82

0.02 (0.17%)

13:45
03/25/19
03/25
13:45
03/25/19
13:45
Options
Realogy call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:45
03/25/19
03/25
13:45
03/25/19
13:45
General news
Euro$ interest rate futures are cracking higher »

Euro$ interest rate…

AAPL

Apple

$188.55

-2.56 (-1.34%)

, GS

Goldman Sachs

$188.87

0.3 (0.16%)

13:43
03/25/19
03/25
13:43
03/25/19
13:43
Hot Stocks
Apple partners with Goldman Sachs, Mastercard to launch Apple Card »

Apple (AAPL) announced…

AAPL

Apple

$188.55

-2.56 (-1.34%)

GS

Goldman Sachs

$188.87

0.3 (0.16%)

MA

MasterCard

$229.47

-1.3 (-0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 15

    Apr

  • 03

    Jun

  • 25

    Jun

AAPL

Apple

$188.55

-2.56 (-1.34%)

13:43
03/25/19
03/25
13:43
03/25/19
13:43
Hot Stocks
Breaking Hot Stocks news story on Apple »

Apple aanounces Apple…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 03

    Jun

CCL

Carnival

$56.60

-0.13 (-0.23%)

, MKC

McCormick

$142.96

0.66 (0.46%)

13:42
03/25/19
03/25
13:42
03/25/19
13:42
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

CCL

Carnival

$56.60

-0.13 (-0.23%)

MKC

McCormick

$142.96

0.66 (0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

  • 26

    Mar

  • 27

    Mar

RHT

Red Hat

$181.76

0.13 (0.07%)

13:42
03/25/19
03/25
13:42
03/25/19
13:42
Earnings
Notable companies reporting after market close »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$188.87

-2.24 (-1.17%)

13:40
03/25/19
03/25
13:40
03/25/19
13:40
Hot Stocks
Breaking Hot Stocks news story on Apple »

Apple CEO Tim Cook says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 03

    Jun

13:39
03/25/19
03/25
13:39
03/25/19
13:39
Conference/Events
Cantor Fitzgerald tech services analyst to hold analyst/industry conference call »

Tech Services Analyst…

AAPL

Apple

$188.31

-2.8 (-1.47%)

13:39
03/25/19
03/25
13:39
03/25/19
13:39
Hot Stocks
Breaking Hot Stocks news story on Apple »

Apple says Apple Card…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 03

    Jun

AAPL

Apple

$188.39

-2.72 (-1.42%)

13:38
03/25/19
03/25
13:38
03/25/19
13:38
Hot Stocks
Breaking Hot Stocks news story on Apple »

Apple says physical card…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 03

    Jun

AAPL

Apple

$188.78

-2.33 (-1.22%)

13:37
03/25/19
03/25
13:37
03/25/19
13:37
Hot Stocks
Breaking Hot Stocks news story on Apple »

Apple says Apple Card…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 03

    Jun

OESX

Orion Energy

$0.91

0.017 (1.90%)

13:36
03/25/19
03/25
13:36
03/25/19
13:36
Hot Stocks
Orion CEO says focused on Enterprise grade LED lighting »

In an exclusive interview…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

AAPL

Apple

$188.96

-2.15 (-1.13%)

, MA

MasterCard

$230.00

-0.77 (-0.33%)

13:36
03/25/19
03/25
13:36
03/25/19
13:36
Hot Stocks
Breaking Hot Stocks news story on Apple, MasterCard »

Apple partered with…

AAPL

Apple

$188.96

-2.15 (-1.13%)

MA

MasterCard

$230.00

-0.77 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 03

    Jun

  • 25

    Jun

EIGR

Eiger BioPharmaceuticals

$13.60

-0.31 (-2.23%)

13:35
03/25/19
03/25
13:35
03/25/19
13:35
Hot Stocks
Eiger announces Phase 2 PREVENT study met primary efficacy endpoint »

Eiger BioPharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$189.34

-1.77 (-0.93%)

, GS

Goldman Sachs

$188.80

0.23 (0.12%)

13:35
03/25/19
03/25
13:35
03/25/19
13:35
Hot Stocks
Breaking Hot Stocks news story on Apple, Goldman Sachs »

Apple partnered with…

AAPL

Apple

$189.34

-1.77 (-0.93%)

GS

Goldman Sachs

$188.80

0.23 (0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 15

    Apr

  • 03

    Jun

AAPL

Apple

$189.25

-1.86 (-0.97%)

13:34
03/25/19
03/25
13:34
03/25/19
13:34
Hot Stocks
Breaking Hot Stocks news story on Apple »

Apple Card has no late…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 03

    Jun

AAPL

Apple

$189.29

-1.82 (-0.95%)

13:33
03/25/19
03/25
13:33
03/25/19
13:33
Hot Stocks
Breaking Hot Stocks news story on Apple »

Apple says Daily Cash…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 03

    Jun

AAPL

Apple

$189.33

-1.78 (-0.93%)

13:32
03/25/19
03/25
13:32
03/25/19
13:32
Hot Stocks
Breaking Hot Stocks news story on Apple »

Apple Card will give 2%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 03

    Jun

AAPL

Apple

$189.76

-1.35 (-0.71%)

13:31
03/25/19
03/25
13:31
03/25/19
13:31
Hot Stocks
Breaking Hot Stocks news story on Apple »

Apple Card has Daily…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 03

    Jun

EADSY

Airbus

$0.00

(0.00%)

13:30
03/25/19
03/25
13:30
03/25/19
13:30
Hot Stocks
Airbus signs agreement with China for 300 aircraft »

Airbus and China Aviation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GM

General Motors

$36.81

0.3 (0.82%)

13:30
03/25/19
03/25
13:30
03/25/19
13:30
Options
7K GM May 34 - 38 put spreads sold $1.54 »

7K GM May 34 - 38 put…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 30

    Apr

AAPL

Apple

$189.90

-1.21 (-0.63%)

13:29
03/25/19
03/25
13:29
03/25/19
13:29
Hot Stocks
Breaking Hot Stocks news story on Apple »

Apple Card in Wallet app,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 03

    Jun

AAPL

Apple

$189.90

-1.21 (-0.63%)

13:28
03/25/19
03/25
13:28
03/25/19
13:28
Hot Stocks
Apple launches Apple News+ subscription service for $9.99 a month in U.S. »

Apple announced Apple…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 03

    Jun

AAPL

Apple

$189.55

-1.56 (-0.82%)

13:27
03/25/19
03/25
13:27
03/25/19
13:27
Hot Stocks
Breaking Hot Stocks news story on Apple »

Apple CEO Tim Cook…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 03

    Jun

AAPL

Apple

$189.50

-1.61 (-0.84%)

13:27
03/25/19
03/25
13:27
03/25/19
13:27
Hot Stocks
Apple adding Apple Pay Transit in Portland, Chicago, NYC later this year »

Apple Pay Transit allows…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 03

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.